期刊文献+

HPLC-荧光法测定人血清中顺式阿曲库铵的浓度 被引量:1

Determination of Cisatracurium Concentration in Human Serum by HPLC-flurorescence Method
原文传递
导出
摘要 目的:建立测定人血清中顺式阿曲库铵浓度的方法。方法:血清酸化后采用二氯甲烷液-液萃取法处理,以高效液相色谱(HPLC)-荧光法进样测定,色谱柱为Kromasil100-5C18,流动相为1.0%三氟乙酸-乙腈(58∶42),流速为0.8ml/min,柱温为常温,荧光检测波长分别为280 nm(E x)、320 nm(E m)。结果:顺式阿曲库铵血药浓度在15.625~2 000ng/ml范围内线性关系良好(r=0.999 3),平均提取回收率为78.78%~83.59%,平均方法回收率为98.58%~101.23%,日内、日间RSD均小于10%。结论:本方法操作简便、灵敏度高、重现性好、结果可靠,可满足临床上血清中顺式阿曲库铵血药浓度检测和药动学研究的需要。 OBJECTIVE: To establish a method for the determination of cisatrcurium concentration in human serum. METHODS: The serum sample was extracted by dichloromethane liquid-liquid extraction after acidification. HPLC-flurorescence method was adopted. The determination was performed on Kromasil 100-5 C18 column with mobile phase consisted of 1.0% TFA-acetonitrile (58:42) at the flow rate of 0.8 ml/min. The column temperature was normal atmospheric temperature; the detection wavelength was set at 280 nm (Ex) and 320 nm (Em). RESULTS: The linear range of cisatracurium was 15.625-2 000 ng/ml (r=0.999 3). Av- erage extraction recovery was 78.78%-83.59%, and average method recovery was 98.58%-101.23%, respectively. The inter-day and intra-day RSDs were less than 10%. CONCLUSIONS: The method is simple, sensitive, reproducible and reliable, and can meet the demand of concentration determination and pharmacokinetics study of cisatracurium.
出处 《中国药房》 CAS CSCD 2014年第42期3983-3984,共2页 China Pharmacy
关键词 顺式阿曲库铵 血药浓度 高效液相色谱-荧光法 Cisatracurium Serum concentration HPLC-flurorescence method
  • 相关文献

参考文献7

二级参考文献45

  • 1上官王宁,连庆泉,陈小玲,李军,Fang Gao Smith.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395-396. 被引量:18
  • 2邱郁薇,李士通.非去极化肌松药相互作用的机制及临床应用[J].国际麻醉学与复苏杂志,2007,28(3):250-252. 被引量:9
  • 3张象麟.药物临床信息参考[M].重庆:重庆出版社,2008:674-675.
  • 4De Ruiter J,Crawford MW.Dose-response relationship and infusion requirement of cisatracurium besylate in in-fants and children during nitrous oxide-narcotic anesthesia[J].Anesthesiology,2001,94 (5):790-792.
  • 5Kenaan CA,Estacio RL,Bikhazi GB.Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia[J].Clinical anaesthesiology,2000,12 (3):1731.
  • 6Taivainen T,Meakin GH,Meretoja OA,et al.The safety and efficacy of cisatracurium 0.15mg∕kg during nitrous oxide-opioid anaesthesia in infants and children[J].Anaesthesia,2000,55 (11):1047-1051.
  • 7David FK,Virginia DS.Clinical Pharmacokinetics of Cisatracurium Besilate[J].Clin Pharmacokinet,1999,36 (1):27-40.
  • 8Adams WA,Mark-Senior J,Jones RS,et al.Cisatracurium in dogs with and without porto-systemic shunts[J].Vet-Anaesth-Analg,2006,33 (1):17-23.
  • 9卢慧勤,郭建荣.顺式阿曲库铵药代学和药效学研究进展[C].2008年第七次华东六省一市麻醉学学术会议暨浙江省麻醉学术年会论文汇编(上册),2008.
  • 10Melloni C,Devivo P,Launo C,et al.Cisatracurium versus vecuronium:A comparative,double blind,randomized,multicenter study in adult patients under propofol/ fentany/ N2O anesthesia[J].Minerva Anestesiol,2006,72(5):299-308.

共引文献24

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部